Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SPCX
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.63% |
| 2 | Financials | 9.78% |
| 3 | Healthcare | 7.32% |
| 4 | Industrials | 7.25% |
| 5 | Consumer Discretionary | 7.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Kulicke & Soffa
KLIC
$4.45B
| $129M | 0.01% |
966,277
+15,793
| +2% | +$1.55M |
|
1352
Cedar Fair
FUN
$1.64B
| $129M | 0.01% |
6,060,863
+136,436
| +2% | +$2.79M |
|
1353
Cytokinetics
CYTK
$10.9B
| $129M | 0.01% |
1,510,318
+5,243
| +0.3% | +$376K |
|
1354
10x Genomics
TXG
$8.5B
| $129M | 0.01% |
3,351,911
+695,558
| +26% | +$18.2M |
|
1355
SK Telecom
SKM
$15.1B
| $128M | 0.01% |
3,994,323
+944,949
| +31% | +$35M |
|
1356
Lincoln National
LNC
$8.33B
| $128M | 0.01% |
3,632,194
-60,648
| -2% | -$2.18M |
|
1357
Elbit Systems
ESLT
$33.6B
| $128M | 0.01% |
169,101
+4,875
| +3% | +$4.05M |
|
1358
Watts Water Technologies
WTS
$12.5B
| $128M | 0.01% |
327,665
+129,141
| +65% | +$40.3M |
|
1359
Oshkosh
OSK
$9.6B
| $128M | 0.01% |
835,651
-33,002
| -4% | -$4.65M |
|
1360
Old Republic International
ORI
$10.1B
| $128M | 0.01% |
3,133,860
+44,826
| +1% | +$1.78M |
|
1361
TAL Education Group
TAL
$6.5B
| $128M | 0.01% |
13,396,879
+451,328
| +3% | +$4.74M |
|
1362
iShares 0-5 Year Investment Grade Corporate Bond ETF
SLQD
$2.39B
| $128M | 0.01% |
2,544,555
+167,293
| +7% | +$8.43M |
|
1363
Energy Fuels
UUUU
$3.95B
| $128M | 0.01% |
8,830,755
+2,559,086
| +41% | +$47M |
|
1364
Avantis US Equity ETF
AVUS
$14.5B
| $128M | 0.01% |
999,429
+26,031
| +3% | +$3.21M |
|
1365
iShares US Industrials ETF
IYJ
$1.92B
| $128M | 0.01% |
767,063
-13,225
| -2% | -$2.08M |
|
1366
MaxLinear
MXL
$5.88B
| $128M | 0.01% |
998,223
+120,153
| +14% | +$8.5M |
|
1367
SPX Corp
SPXC
$10.2B
| $128M | 0.01% |
520,845
+60,092
| +13% | +$13.1M |
|
1368
Primoris Services
PRIM
$4.15B
| $127M | 0.01% |
1,284,470
+728,723
| +131% | +$95.8M |
|
1369
abrdn Physical Precious Metals Basket Shares ETF
GLTR
$2.83B
| $127M | 0.01% |
701,720
+36,570
| +5% | +$7.73M |
|
1370
Axogen
AXGN
$2.77B
| $127M | 0.01% |
2,747,924
-375,058
| -12% | -$15.1M |
|
1371
XPeng
XPEV
$10.9B
| $127M | 0.01% |
9,586,523
+4,137,650
| +76% | +$65.6M |
|
1372
Granite Construction
GVA
$5.47B
| $126M | 0.01% |
799,000
-51,159
| -6% | -$6.95M |
|
1373
Blue Owl Capital
OWL
$8.29B
| $126M | 0.01% |
14,434,733
+1,207,148
| +9% | +$11.5M |
|
1374
BridgeBio Pharma
BBIO
$15.4B
| $126M | 0.01% |
1,693,652
-183,707
| -10% | -$12.9M |
|
1375
iShares US Medical Devices ETF
IHI
$3.39B
| $126M | 0.01% |
2,549,908
-678,388
| -21% | -$34.4M |
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 423 new, 3,809 increased, 3,216 reduced and 305 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 423 new positions and closed 305 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.